Bioinks

  • BICO, an expert bio convergence company, has been granted two patents relating to the regulation and control of temperatures in 3D Bioprinters. The first patent, US 11,046,001, was granted in the United States and relates to the temperature regulation of bioinks which allows for better cell viability during 3D bioprinting.…

    Read More
  • Jellagen, a biotech company developing a proprietary next-generation biomaterial, Collagen Type 0, entered a partnership with Copner Biotech, a pioneer in 3D bioprinting, after securing innovation funding of £123,724 from SMART Cymru. Professor Andrew Mearns Spragg, Founder and Chief Scientific Officer of Jellagen commented “We are absolutely delighted to partner…

    Read More
  • The Humabiologics human-derived hydrogels for regenerative medicine are now ISO 13485:2016 certified as well as GMP compliant for the manufacturing of human-derived biomaterials. The scope of the certificate covers the design, manufacture, and distribution of human biomaterials, components, and sub-assemblies for use in research and development, medical devices, pharmaceuticals, and…

    Read More
  • First presented at Bio Digital 2020, Rousselot‘s X-Pure GelMA is the world’s first GMP-ready gelatin methacryloyl (GelMA or Gel-MOD) for preclinical and clinical applications in regenerative medicine. GelMA is a gold-standard biomaterial, ideal as a bioink for 3D bioprinting and tissue engineering, owing to its guaranteed ultra-low impurity levels and…

    Read More
  • After so many years of anticipation and excitement for the possibilities it could offer, the bioprinting segment now seems to finally be coming into its own. The bioprinting market is starting to take shape, setting the foundations for future growth, while large medical and pharmaceutical firms look at this field…

    Read More
  • Bio-convergence company BICO has acquired all outstanding shares in Advanced BioMatrix Corp, an American company focusing on 3D research applications. The company’s portfolio includes collagen bioinks, high purity extracellular matrix proteins, chemically modified proteins, and polysaccharides, and other reagents and cell assays, sold to research institutions, and pharmaceutical and biotech companies.…

    Read More
  • Humabiologics, an industry expert in providing human-derived biomaterials for regenerative medicine, and Allegro 3D, an emerging 3D bioprinting company, are partnering to accelerate the development of tissue models for drug screening and regenerative medicine therapies. Humabiologics develops and commercializes high-quality and affordable human-derived biomaterials for translational regenerative medicine applications such…

    Read More
  • Humabiologics introduced the world’s first native human collagen bioinks and gelatin bioinks. These bioinks are affordable and more clinically relevant, enabling researchers to advance the translational research of bioprinted human organs and tissues. The company was founded by current CEO Mohammad Albanna, leveraging extensive experience in the field of Tissue…

    Read More
  • Rousselot, a global leader in collagen-based solutions, introduced the X-Pure GelMA bioinks at Bio Digital 2020. The first GMP-ready range of gelatin methacryloyl (GelMA) biomaterials suitable for preclinical and clinical applications, X-Pure GelMA is part of the X-Pure portfolio of ultra-pure gelatins and collagens, suitable for use as biomaterials in…

    Read More
Back to top button

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services

STAY AHEAD

OF THE CURVE

Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*

WELCOME ON BOARD!